Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects

被引:0
作者
Reza Elahi
Amir Hossein Heidary
Kaveh Hadiloo
Abdolreza Esmaeilzadeh
机构
[1] Zanjan University of Medical Sciences,School of Medicine
[2] Zanjan University of Medical Sciences,Department of Immunology
[3] Zanjan University of Medical Sciences,Cancer Gene Therapy Research Center (CGRC)
[4] Zanjan University of Medical Sciences,undefined
来源
Stem Cell Reviews and Reports | 2021年 / 17卷
关键词
Chimeric antigen receptor; Natural killer cell; Immunotherapy; Challenges; Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2081 / 2106
页数:25
相关论文
共 50 条
  • [21] Chimeric antigen receptor (CAR)-modified NK cells against cancer: Opportunities and challenges
    Wang, Luyao
    Dou, Mei
    Ma, Qingxia
    Yao, Ruixue
    Liu, Jia
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 74
  • [22] Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
    Ying Gong
    Roel G. J. Klein Wolterink
    Jianxiang Wang
    Gerard M. J. Bos
    Wilfred T. V. Germeraad
    Journal of Hematology & Oncology, 14
  • [23] Chimeric antigen receptor (CAR) NK cells for the treatment of allergy
    Zabel, Maja
    Kratzer, Bernhard
    Trapin, Doris
    Steinberger, Peter
    Eitler, Jiri
    Tonn, Torsten
    Pickl, Winfried F.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 351 - 351
  • [24] The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
    Yao, Pin
    Liu, Ya-Guang
    Huang, Gang
    Hao, Liangchun
    Wang, Runan
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [25] Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
    Gong, Ying
    Klein Wolterink, Roel G. J.
    Wang, Jianxiang
    Bos, Gerard M. J.
    Germeraad, Wilfred T. V.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [26] Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
    Ethan Q Han
    Xiu-ling Li
    Chun-rong Wang
    Tian-fang Li
    Shuang-yin Han
    Journal of Hematology & Oncology, 6
  • [27] Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
    Han, Ethan Q.
    Li, Xiu-ling
    Wang, Chun-rong
    Li, Tian-fang
    Han, Shuang-yin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [28] Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
    Mehta, Rohtesh S.
    Rezvani, Katayoun
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [29] Development of c-MET-specific chimeric antigen receptor-engineered natural killer cells with cytotoxic effects on human liver cancer HepG2 cells
    Liu, Bing
    Liu, Zheng-Zhi
    Zhou, Mei-Ling
    Lin, Jian-Wei
    Chen, Xue-Mei
    Li, Zhu
    Gao, Wen-Bin
    Yu, Zhen-Dong
    Liu, Tao
    MOLECULAR MEDICINE REPORTS, 2019, 20 (03) : 2823 - 2831
  • [30] Chimeric antigen receptor-engineered T cells in CLL: the next chapter unfolds
    Kalos, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4